Oil made its way to $49 a barrel today, no thanks to high output from Middle East OPEC members and a stronger U.S. dollar. Also a factor, profit taking in oil and worries about a U.S. interest rate hike rattling an already nervous market. Swiss drug maker Roche says the FDA has issued an "emergency use authorization" for its Zika test. The name of the product is "The Lightmix Zika Test". It's a user friendly molecular diagnostic test. Also, Amazon (AMZN) is testing out 30 hour work weeks with some of its employees. The program will have a few technical teams made up entirely of part-time workers.. These employees will be salaried and receive the same benefits as traditional 40-hour workers, but will receive only 75 percent of the pay. Joya Dass reports from he Nasdaq Marketsite in Times Square.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.